Your browser doesn't support javascript.
loading
Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing.
Sifrim, Alejandro; Hitz, Marc-Phillip; Wilsdon, Anna; Breckpot, Jeroen; Turki, Saeed H Al; Thienpont, Bernard; McRae, Jeremy; Fitzgerald, Tomas W; Singh, Tarjinder; Swaminathan, Ganesh Jawahar; Prigmore, Elena; Rajan, Diana; Abdul-Khaliq, Hashim; Banka, Siddharth; Bauer, Ulrike M M; Bentham, Jamie; Berger, Felix; Bhattacharya, Shoumo; Bu'Lock, Frances; Canham, Natalie; Colgiu, Irina-Gabriela; Cosgrove, Catherine; Cox, Helen; Daehnert, Ingo; Daly, Allan; Danesh, John; Fryer, Alan; Gewillig, Marc; Hobson, Emma; Hoff, Kirstin; Homfray, Tessa; Kahlert, Anne-Karin; Ketley, Ami; Kramer, Hans-Heiner; Lachlan, Katherine; Lampe, Anne Katrin; Louw, Jacoba J; Manickara, Ashok Kumar; Manase, Dorin; McCarthy, Karen P; Metcalfe, Kay; Moore, Carmel; Newbury-Ecob, Ruth; Omer, Seham Osman; Ouwehand, Willem H; Park, Soo-Mi; Parker, Michael J; Pickardt, Thomas; Pollard, Martin O; Robert, Leema.
Affiliation
  • Sifrim A; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Hitz MP; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Wilsdon A; Department of Congenital Heart Disease and Pediatric Cardiology, Universitätsklinikum Schleswig-Holstein Kiel, Kiel, Germany.
  • Breckpot J; German Center for Cardiovascular Research (DZHK), Berlin, Germany.
  • Turki SH; School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK.
  • Thienpont B; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium.
  • McRae J; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Fitzgerald TW; Department of Pathology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Singh T; Genetics Training Program, Harvard Medical School, Boston, Massachusetts, USA.
  • Swaminathan GJ; Vesalius Research Center, VIB, Leuven, Belgium.
  • Prigmore E; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Rajan D; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Abdul-Khaliq H; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Banka S; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Bauer UM; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Bentham J; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Berger F; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Bhattacharya S; Department of Pediatric Cardiology, Saarland University, Homburg, Germany.
  • Bu'Lock F; Competence Network for Congenital Heart Defects, National Register for Congenital Heart Defects, DZHK, Berlin, Germany.
  • Canham N; Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK.
  • Colgiu IG; Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Cosgrove C; Competence Network for Congenital Heart Defects, National Register for Congenital Heart Defects, DZHK, Berlin, Germany.
  • Cox H; Department of Paediatric Cardiology, Yorkshire Heart Centre, Leeds, UK.
  • Daehnert I; German Center for Cardiovascular Research (DZHK), Berlin, Germany.
  • Daly A; Competence Network for Congenital Heart Defects, National Register for Congenital Heart Defects, DZHK, Berlin, Germany.
  • Danesh J; Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Institute Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Fryer A; Department of Cardiovascular Medicine, University of Oxford, Oxford, UK.
  • Gewillig M; East Midlands Congenital Heart Centre, Glenfield Hospital, Leicester, UK.
  • Hobson E; North West Thames Regional Genetics Centre, London North West Healthcare NHS Trust, Harrow, UK.
  • Hoff K; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Homfray T; Department of Cardiovascular Medicine, University of Oxford, Oxford, UK.
  • Kahlert AK; Competence Network for Congenital Heart Defects, National Register for Congenital Heart Defects, DZHK, Berlin, Germany.
  • Ketley A; Department of Pediatric Cardiology, Heart Center, University of Leipzig, Leipzig, Germany.
  • Kramer HH; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Lachlan K; Wellcome Trust Sanger Institute, Cambridge, UK.
  • Lampe AK; NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Louw JJ; INTERVAL Coordinating Centre, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Manickara AK; Department of Clinical Genetics, Liverpool Women's NHS Foundation Trust, Liverpool, UK.
  • Manase D; Department of Pediatric Cardiology, University Hospitals Leuven, Leuven, Belgium.
  • McCarthy KP; Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Department of Clinical Genetics, Chapel Allerton Hospital, Leeds, UK.
  • Metcalfe K; Department of Congenital Heart Disease and Pediatric Cardiology, Universitätsklinikum Schleswig-Holstein Kiel, Kiel, Germany.
  • Moore C; German Center for Cardiovascular Research (DZHK), Berlin, Germany.
  • Newbury-Ecob R; South West Thames Regional Genetics Centre, St George's Healthcare NHS Trust, University of London, London, UK.
  • Ouwehand WH; Department of Congenital Heart Disease and Pediatric Cardiology, Universitätsklinikum Schleswig-Holstein Kiel, Kiel, Germany.
  • Park SM; German Center for Cardiovascular Research (DZHK), Berlin, Germany.
  • Parker MJ; Institute for Clinical Genetics, Carl Gustav Carus Faculty of Medicine, Dresden, Germany.
  • Pickardt T; School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK.
  • Pollard MO; Department of Congenital Heart Disease and Pediatric Cardiology, Universitätsklinikum Schleswig-Holstein Kiel, Kiel, Germany.
  • Robert L; German Center for Cardiovascular Research (DZHK), Berlin, Germany.
Nat Genet ; 48(9): 1060-5, 2016 09.
Article in En | MEDLINE | ID: mdl-27479907
ABSTRACT
Congenital heart defects (CHDs) have a neonatal incidence of 0.8-1% (refs. 1,2). Despite abundant examples of monogenic CHD in humans and mice, CHD has a low absolute sibling recurrence risk (∼2.7%), suggesting a considerable role for de novo mutations (DNMs) and/or incomplete penetrance. De novo protein-truncating variants (PTVs) have been shown to be enriched among the 10% of 'syndromic' patients with extra-cardiac manifestations. We exome sequenced 1,891 probands, including both syndromic CHD (S-CHD, n = 610) and nonsyndromic CHD (NS-CHD, n = 1,281). In S-CHD, we confirmed a significant enrichment of de novo PTVs but not inherited PTVs in known CHD-associated genes, consistent with recent findings. Conversely, in NS-CHD we observed significant enrichment of PTVs inherited from unaffected parents in CHD-associated genes. We identified three genome-wide significant S-CHD disorders caused by DNMs in CHD4, CDK13 and PRKD1. Our study finds evidence for distinct genetic architectures underlying the low sibling recurrence risk in S-CHD and NS-CHD.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantigens / Protein Kinase C / CDC2 Protein Kinase / Mi-2 Nucleosome Remodeling and Deacetylase Complex / Heart Defects, Congenital / Mutation Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2016 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantigens / Protein Kinase C / CDC2 Protein Kinase / Mi-2 Nucleosome Remodeling and Deacetylase Complex / Heart Defects, Congenital / Mutation Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2016 Document type: Article Affiliation country: Reino Unido